Iodine-123 is a radioactive isotope of iodine used in Nuclear Medicine and Radiopharmacology. It is used in a variety of medical imaging procedures, such as thyroid scans, to diagnose and treat thyroid diseases. It is also used in the diagnosis of certain types of cancer, such as neuroendocrine tumors. Iodine-123 has a short half-life of 13.2 hours, making it ideal for use in Nuclear Medicine. It is produced in nuclear reactors and cyclotrons, and is available in a variety of formulations, including capsules, solutions, and injectables. Companies in the Iodine-123 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Jubilant DraxImage, and Bracco Diagnostics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
